Michele Bialecki

Michele Bialecki, PhD, is a Senior Clinical Scientist at Merck, where they have been engaged since 2021. Prior to this role, they served as a Clinical Scientist for Execupharm from 2019 to 2021 and worked as an Associate Clinical Scientist at Inovio Pharmaceuticals Inc. from 2018 to 2019, where they contributed to vaccine trials and managed clinical study operations. Michele also has experience as a Lab Manager and Research Associate at Cornell University, focusing on influenza research, and worked as an Adjunct Faculty member at Pennsylvania College of Technology, teaching Anatomy and Physiology. They hold a PhD in Comparative Biomedical Sciences from Cornell University and are currently pursuing degrees in Cellular and Organismal Biology and Secondary Education at Lock Haven University of Pennsylvania.